Study outcomes
LVM, LV end-systolic volume (LVESV), LV end-diastolic volume (LVEDV) and LV ejection fraction (LVEF) were measured at the baseline and month 6 study visits. For statistical analyses, LVM, LVESV and LVEDV were also indexed against the participants’ baseline BSA. After the impact of placebo and empagliflozin assignment on the 6-month changes in LVEF as well as those of indexed and non-indexed LVM, LVESV and LVEDV were determined, the data were stratified into the South Asian and non-South Asian categories.